MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$360,519K
Net Income
$83,496K
Net Profit Margin
23.16%
EPS
$0.92
Unit: Thousand (K) dollars
Revenue Breakdown
US
Royalty
All Other Countries Other Than R...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
360,519
272,551
164,677
211,007
Cost of product, collaboration and license sales, excluding amortization of acquired intangible assets
19,921
28,028
6,950
15,781
Amortization of acquired intangible assets
11,841
11,581
9,349
7,534
Research and development
99,150
100,873
133,128
100,158
Selling, general and administrative
80,630
86,183
96,874
84,046
Change in the fair value of contingent consideration
-
-
0
-
Tangible asset impairment and losses on transactions, net
-
-927
10,275
-472
Total operating expenses
211,542
227,592
236,026
207,991
Income (gain) from operations
148,977
44,959
-71,349
3,016
Interest expense, net
-48,481
-49,030
-55,188
-32,592
Other expense, net
-2,951
1,609
-12,546
6,502
Income (gain) before income tax (expense) benefit
97,545
-2,462
-139,083
-23,074
Income tax (expense) benefit
14,049
347
-4,118
-38,970
Net income (gain) attributable to common stockholders
83,496
-2,809
-134,965
15,896
Basic EPS
1.01
-0.03
-1.618
0.2
Diluted EPS
0.92
-0.03
-1.328
0.2
Basic Average Shares
83,006,808
82,521,023
83,398,965
78,471,119
Diluted Average Shares
92,020,009
82,521,023
101,593,445
87,115,369
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
US
$152,184K
All Other Countries
Other Than Russia...
$52,844K
BR
$25,581K
RU
$8,210K
Product
$238,819K
(101.83%↑ Y/Y)
Royalty
$71,105K
(23.44%↑ Y/Y)
Collaboration And License
Revenue
$50,595K
(1620.33%↑ Y/Y)
Total revenues
$360,519K
(101.55%↑ Y/Y)
Income (gain) from
operations
$148,977K
(526.17%↑ Y/Y)
Total operating
expenses
$211,542K
(-1.07%↓ Y/Y)
Income (gain) before
income tax (expense)...
$97,545K
(237.29%↑ Y/Y)
Interest expense, net
-$48,481K
(-59.70%↓ Y/Y)
Other expense, net
-$2,951K
(48.56%↑ Y/Y)
Research and development
$99,150K
(-12.25%↓ Y/Y)
Selling, general and
administrative
$80,630K
(-5.43%↓ Y/Y)
Cost of product,
collaboration and license...
$19,921K
(74.44%↑ Y/Y)
Amortization of acquired
intangible assets
$11,841K
(191.58%↑ Y/Y)
Net income (gain)
attributable to common...
$83,496K
(228.75%↑ Y/Y)
Income tax (expense)
benefit
$14,049K
(326.49%↑ Y/Y)
Buy us a coffee
PTC THERAPEUTICS, INC. (PTCT)
PTC THERAPEUTICS, INC. (PTCT)